A detailed history of Invesco Ltd. transactions in Care Dx, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 1,463,690 shares of CDNA stock, worth $30.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,463,690
Previous 90,739 1513.08%
Holding current value
$30.6 Million
Previous $1.41 Million 3143.15%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$14.41 - $33.99 $19.8 Million - $46.7 Million
1,372,951 Added 1513.08%
1,463,690 $45.7 Million
Q2 2024

Aug 13, 2024

SELL
$7.56 - $16.15 $9,087 - $19,412
-1,202 Reduced 1.31%
90,739 $1.41 Million
Q1 2024

May 14, 2024

BUY
$7.96 - $12.37 $236,611 - $367,698
29,725 Added 47.78%
91,941 $973,000
Q4 2023

Feb 12, 2024

BUY
$4.9 - $12.86 $59,123 - $155,168
12,066 Added 24.06%
62,216 $746,000
Q3 2023

Nov 13, 2023

BUY
$7.0 - $11.26 $2,506 - $4,031
358 Added 0.72%
50,150 $351,000
Q2 2023

Aug 11, 2023

SELL
$7.61 - $9.46 $50,781 - $63,126
-6,673 Reduced 11.82%
49,792 $423,000
Q1 2023

May 12, 2023

SELL
$8.83 - $17.61 $282,171 - $562,745
-31,956 Reduced 36.14%
56,465 $516,000
Q4 2022

Feb 13, 2023

BUY
$10.88 - $20.05 $193,653 - $356,869
17,799 Added 25.2%
88,421 $1.01 Million
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $30.7 Million - $50.5 Million
-1,912,769 Reduced 96.44%
70,622 $1.2 Million
Q2 2022

Aug 15, 2022

SELL
$20.49 - $39.72 $5.13 Million - $9.94 Million
-250,205 Reduced 11.2%
1,983,391 $42.6 Million
Q1 2022

May 16, 2022

SELL
$28.19 - $46.6 $12.2 Million - $20.1 Million
-431,666 Reduced 16.2%
2,233,596 $82.6 Million
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $13.8 Million - $24.6 Million
-334,078 Reduced 11.14%
2,665,262 $121 Million
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $2.36 Million - $3.67 Million
39,945 Added 1.35%
2,999,340 $190 Million
Q2 2021

Aug 17, 2021

SELL
$63.02 - $95.11 $2.81 Million - $4.25 Million
-44,661 Reduced 1.49%
2,959,395 $271 Million
Q1 2021

May 17, 2021

SELL
$57.62 - $95.6 $3.64 Million - $6.03 Million
-63,119 Reduced 2.06%
3,004,056 $205 Million
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $1.53 Million - $2.84 Million
36,837 Added 1.22%
3,067,175 $222 Million
Q3 2020

Nov 16, 2020

SELL
$30.88 - $37.94 $891,382 - $1.1 Million
-28,866 Reduced 0.94%
3,030,338 $115 Million
Q2 2020

Aug 14, 2020

BUY
$18.95 - $35.43 $5.66 Million - $10.6 Million
298,722 Added 10.82%
3,059,204 $108 Million
Q1 2020

May 15, 2020

BUY
$13.94 - $28.25 $28 Million - $56.7 Million
2,005,791 Added 265.78%
2,760,482 $60.3 Million
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $241,923 - $357,227
-12,574 Reduced 1.64%
754,691 $16.3 Million
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $2.94 Million - $5.89 Million
146,954 Added 23.69%
767,265 $17.3 Million
Q2 2019

Aug 14, 2019

BUY
$25.78 - $39.77 $5.39 Million - $8.32 Million
209,232 Added 50.9%
620,311 $22.3 Million
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $2.2 Million - $3.9 Million
-99,392 Reduced 19.47%
411,079 $13 Million
Q4 2018

Feb 14, 2019

BUY
$19.89 - $30.02 $10.2 Million - $15.3 Million
510,471 New
510,471 $12.8 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.12B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.